Evidence base
This section provides links and a brief summary of a robust evidence base. For example, peer-reviewd studies, systematic revies, evaluations of interventions and best practice guidelines from national sources.
|
Issue number 1 = highest priority |
|
|
|
1 |
Source |
Cancer Research UK |
|
Title incl. web link |
New calculations confirm lifestyle changes could prevent 4 in 10 cancer cases. |
|
|
Summary |
The report states more than 135,000 cancer cases in the UK each year could be prevented through lifestyle changes including:
|
|
|
Source |
Pour-Rashidi, A., Yazdanpanah, N., Rezaei, N. (2023). Introduction on Cancer Modifiable Risk Factors and Prevention. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham. https://doi.org/10.1007/978-3-030-80962-1_319-1 |
|
|
Title incl. web link |
Introduction on Cancer Modifiable Risk Factors and Prevention Introduction on Cancer Modifiable Risk Factors and Prevention | SpringerLink |
|
|
Summary |
Emphasises that prevention strategies such as smoking cessation, dietary changes and physical activity are increasingly effective due to growing scientific understanding. |
|
|
2 |
Source |
Cancer Research UK |
|
Title incl. web link |
Be Clear on Cancer |
|
|
Summary |
The campaign ran between 2011 and 2018 and demonstrated measurable success in raising awareness of cancer symptoms and encourage earlier diagnosis.
|
|
|
Source |
NHS England |
|
|
Title incl. web link |
In the spotlight…. ‘help us, help you’ |
|
|
Summary |
The campaign replaced the Be Clear on Cancer programme and was designed to encourage earlier diagnosis by raising awareness of symptoms and urging people to seek medical advice promptly. Key phases:
Lung Cancer (Spring 2021) – Highlighted persistent coughs lasting 3 or more weeks, especially in those over 60 and in deprived communities. |
|
|
3 |
Source |
Cancer Research UK |
|
Title incl. web link |
Cancer inequalities: The problem of unwarranted variation in access to treatment |
|
|
Summary |
Highlights that unwarranted variation in access to treatment is a persistent issue.
|
|
|
Source |
Centre for Cancer Genetic Epidemiology, University of Cambridge |
|
|
Title incl. web link |
Cancer Data Driven Detection (CD3) Programme Cancer Data Driven Detection (CD3) Programme | Centre For Cancer Genetic Epidemiology |
|
|
Summary |
CD3 aims to:
|
|
|
4 |
Source |
NHS England |
|
Title incl. web link |
Screening and earlier diagnosis |
|
|
Summary |
Cancer screening programmes help to diagnose cancer or cancer risk earlier and improve the likelihood of successful treatment.
|
|
|
Source |
Cancer Research UK |
|
|
Title incl. web link |
Guide to GP Contract 2025/26 |
|
|
Summary |
PCNs are expected to:
|
|